<DOC>
	<DOCNO>NCT02546856</DOCNO>
	<brief_summary>Introduction : Heart Failure ( HF ) generate multiple hospital admission mortality , reduce administration Beta-Blocker ( BB ) , Angiotensin Converting Enzyme Inhibitor ( ACEI ) , Angiotensin II Receptor Blocker ( ARB ) Mineralocorticoid Receptor Antagonist ( MRA ) drug ( Level Evidence A ) . The effect dose-dependent . Nevertheless , dosages suboptimal . European Guidelines 2012 recommend close monitoring up-titration drug HF nurse . Trials need evaluate effectiveness safety . Objective : To compare dos achieve patient BB , ACEI , ARA II ARM 4 month ( % relative target dos ) intervention group ( HF nurse ) control group ( cardiologist ) , adverse event , Left Ventricular Ejection Fraction ( LVEF ) , New York Heart Association ( NYHA ) , 6 min . walk test , quality life , Nt-proBNP , readmission mortality . Hypothesis : Non-inferiority . Design : Multicenter randomize control trial . New ( `` de novo '' ) HF patient LVEF â‰¤ 40 % , NYHA II-III , without contraindication BB 17 Spanish hospital include . Intervention : The cardiologist prescribes drug , drive protocol , HF nurse implement up-titration . In control group dose decide cardiologist clinical support education provide nurse . Variables : age , sex , education , psycho-social level , Cardio Vascular Risk Factors ( CVRF ) , NYHA , LVEF , ischemic cardiopathy. , N-terminal pro B-type natriuretic peptide ( Nt-proBNP ) , 6min . walk test , Creatinine/Glomedular Filtration Rate ( GFR ) , Potassium ( K ) , haemoglobin , Blood Preassure ( BP ) , Heart Rate ( HR ) , mg./drug , European Heart Failure Self-Care Behaviour Scale ( EHFScBS ) , Minnesota Living Heart Failure questionnaire ( MLHFQ ) , European Quality life Scale ( EQ-5D ) . Expected Results : If hypothesis confirm , evidence would provide effectiveness healthcare management , could economically evaluate future study . A qualitative study also undertaken explore barrier facilitator implementation</brief_summary>
	<brief_title>Safety Effectiveness Drug Titration Nurses Specialized Heart Failure ( HF ) Patients</brief_title>
	<detailed_description>No apply</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Mineralocorticoid Receptor Antagonists</mesh_term>
	<mesh_term>Enzyme Inhibitors</mesh_term>
	<mesh_term>Angiotensin-Converting Enzyme Inhibitors</mesh_term>
	<mesh_term>Mineralocorticoids</mesh_term>
	<mesh_term>Angiotensin Receptor Antagonists</mesh_term>
	<criteria>Patient `` de novo '' heart Failure LVEF &lt; = 40 % admitted hospital , without contraindication BB prescription cardiologist uptitration prescription without achieve BB target dose previous discharge signing informed consent . Contraindications BB . Living nursing home . Life expectancy &lt; 6 month . Unable selfcare mental disease without caregiver . Unable weight Without phone Unable go clinic visit .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>